Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ROBERT EDWARD SCHWARTZ

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1942410063
CMS profile
817154
Location
NEW YORK, NY

General Payments · PY2018–2024

$80,664.50

  • Reported across 73 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$42,440.72

24 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $26,291.12 9
Alnylam Pharmaceuticals Inc. $16,149.60 15

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $3,471.38 8
PY2019 $2,973.79 5
PY2020 $5,632.00 4
PY2021 $2,553.35 3
PY2022 $15,442.61 19
PY2023 $8,150.65 10
PY2024 $42,440.72 24

Payment records · PY2024 (24)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alnylam Pharmaceuticals Inc. $3,330.00 01/05/2024 Consulting Fee Undisputed 01/23/2026 1125830339 CMS
Alnylam Pharmaceuticals Inc. $88.00 01/05/2024 Travel and Lodging Undisputed 01/23/2026 1125830341 CMS
Alnylam Pharmaceuticals Inc. $925.00 07/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1125830403 CMS
Alnylam Pharmaceuticals Inc. $256.96 10/29/2024 Travel and Lodging Undisputed 01/23/2026 1125830495 CMS
Alnylam Pharmaceuticals Inc. $203.61 10/29/2024 Travel and Lodging Undisputed 01/23/2026 1125830497 CMS
Alnylam Pharmaceuticals Inc. $124.99 10/29/2024 Food and Beverage Undisputed 01/23/2026 1125830499 CMS
Alnylam Pharmaceuticals Inc. $124.99 11/21/2024 Food and Beverage Undisputed 01/23/2026 1125830471 CMS
Alnylam Pharmaceuticals Inc. $696.79 11/21/2024 Travel and Lodging Undisputed 01/23/2026 1125830479 CMS
Alnylam Pharmaceuticals Inc. $2,394.40 11/21/2024 Travel and Lodging Undisputed 01/23/2026 1125830481 CMS
Alnylam Pharmaceuticals Inc. $2,590.00 12/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1125830501 CMS
Alnylam Pharmaceuticals Inc. $221.02 12/02/2024 Travel and Lodging Undisputed 01/23/2026 1125830503 CMS
Alnylam Pharmaceuticals Inc. $10.64 12/02/2024 Food and Beverage Undisputed 01/23/2026 1125830505 CMS
Alnylam Pharmaceuticals Inc. $179.53 12/19/2024 Food and Beverage Undisputed 01/23/2026 1125830473 CMS
Alnylam Pharmaceuticals Inc. $193.67 12/19/2024 Travel and Lodging Undisputed 01/23/2026 1125830475 CMS
Alnylam Pharmaceuticals Inc. $4,810.00 12/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1125830477 CMS
Novo Nordisk Inc $308.92 04/13/2024 Food and Beverage Undisputed 01/23/2026 1096571758 CMS
Novo Nordisk Inc $665.79 04/13/2024 Travel and Lodging Undisputed 01/23/2026 1096754569 CMS
Novo Nordisk Inc $12,206.25 04/13/2024 Consulting Fee Undisputed 01/23/2026 1097322958 CMS
Novo Nordisk Inc $1,205.14 04/13/2024 Travel and Lodging Undisputed 01/23/2026 1097493853 CMS
Novo Nordisk Inc $210.44 04/13/2024 Travel and Lodging Undisputed 01/23/2026 1097495641 CMS
Novo Nordisk Inc $10,268.75 09/20/2024 Consulting Fee Undisputed 01/23/2026 1096568958 CMS
Novo Nordisk Inc $199.95 09/20/2024 Food and Beverage Undisputed 01/23/2026 1097323025 CMS
Novo Nordisk Inc $876.82 09/20/2024 Travel and Lodging Undisputed 01/23/2026 1097497697 CMS
Novo Nordisk Inc $349.06 09/20/2024 Travel and Lodging Undisputed 01/23/2026 1097498639 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.